Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients Medical Dialogues Bureau29 March 2020 6:45 AM GMTVenclexta/Venclyxto is being developed by AbbVie and Roche.
Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine Farhat Nasim22 May 2019 4:15 AM GMTAzacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...